Analysts See $-0.10 EPS for DelMar Pharmaceuticals, Inc. (DMPI); Bofi Holding (BOFI) Shorts Down By 5.83%

April 23, 2018 - By Linda Rogers

DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) Logo

Bofi Holding Inc (NASDAQ:BOFI) had a decrease of 5.83% in short interest. BOFI’s SI was 13.14 million shares in April as released by FINRA. Its down 5.83% from 13.95M shares previously. With 792,900 avg volume, 17 days are for Bofi Holding Inc (NASDAQ:BOFI)’s short sellers to cover BOFI’s short positions. The SI to Bofi Holding Inc’s float is 23.51%. The stock increased 1.36% or $0.56 during the last trading session, reaching $41.81. About 331,664 shares traded. BofI Holding, Inc. (NASDAQ:BOFI) has risen 42.81% since April 23, 2017 and is uptrending. It has outperformed by 31.26% the S&P500.

Analysts expect DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) to report $-0.10 EPS on May, 11.They anticipate $0.08 EPS change or 44.44% from last quarter’s $-0.18 EPS. After having $-0.14 EPS previously, DelMar Pharmaceuticals, Inc.’s analysts see -28.57% EPS growth. The stock decreased 2.92% or $0.03 during the last trading session, reaching $1. About 96,204 shares traded. DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) has declined 76.10% since April 23, 2017 and is downtrending. It has underperformed by 87.65% the S&P500.

DelMar Pharmaceuticals, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients who have failed to respond to modern therapy. The company has market cap of $21.93 million. The Company’s product candidate includes VAL-083, a small-molecule chemotherapeutic agent, which has completed Phase I/II study to evaluate the safety, tolerability, pharmacokinetics, and anti-cancer activity in patients with glioblastoma multiforme, a form of brain cancer. It currently has negative earnings. The firm has a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company for the manufacture and sale of VAL-083 in China; collaboration agreement with the University of Texas MD Anderson Cancer Center; and collaboration agreement with Accurexa Inc. to develop a novel formulation for the local delivery of combination chemotherapy for the treatment of brain cancer and other solid tumors.

BofI Holding, Inc. operates as the holding firm for BofI Federal Bank that provides consumer and business banking products in the United States. The company has market cap of $2.61 billion. The firm offers deposits products, including consumer and business checking, demand, savings, and time deposit accounts. It has a 19.82 P/E ratio. It also provides single family and multifamily mortgage secured lending products; commercial real estate secured and commercial lending products; specialty finance factoring products; and consumer lending products consisting of prime loans to purchase new and used automobiles and recreational vehicles, as well as deposit-related overdraft lines of credit.

Since March 8, 2018, it had 0 insider buys, and 1 insider sale for $362,959 activity. $362,959 worth of stock was sold by COURT JAMES JOHN on Thursday, March 8.

Investors sentiment increased to 1.29 in 2017 Q4. Its up 0.31, from 0.98 in 2017Q3. It improved, as 21 investors sold BofI Holding, Inc. shares while 59 reduced holdings. 38 funds opened positions while 65 raised stakes. 51.03 million shares or 0.73% less from 51.41 million shares in 2017Q3 were reported. 7,655 are owned by Jefferies Gru Ltd Limited Liability Company. Spectrum Asset Management Inc (Nb Ca) invested 0.98% in BofI Holding, Inc. (NASDAQ:BOFI). Stoneridge Prns Ltd Co holds 0.04% or 7,527 shares in its portfolio. Bowling Portfolio Management Ltd Liability stated it has 0.15% in BofI Holding, Inc. (NASDAQ:BOFI). Texas Permanent School Fund holds 0.01% in BofI Holding, Inc. (NASDAQ:BOFI) or 37,866 shares. Atlantic Group Lc holds 0% or 146 shares. The Pennsylvania-based Cim Invest Mangement has invested 0.11% in BofI Holding, Inc. (NASDAQ:BOFI). Qs Investors Ltd Liability Company holds 0.07% or 260,658 shares in its portfolio. First Republic Mngmt has 0% invested in BofI Holding, Inc. (NASDAQ:BOFI). Zurcher Kantonalbank (Zurich Cantonalbank) has invested 0% of its portfolio in BofI Holding, Inc. (NASDAQ:BOFI). Geode Capital Mngmt Ltd Liability has 0.01% invested in BofI Holding, Inc. (NASDAQ:BOFI) for 524,069 shares. Stieven Capital Advisors L P invested 2.94% in BofI Holding, Inc. (NASDAQ:BOFI). Van Hulzen Asset Management Llc reported 0.06% of its portfolio in BofI Holding, Inc. (NASDAQ:BOFI). The Illinois-based Nuveen Asset Mgmt Limited Liability has invested 0.09% in BofI Holding, Inc. (NASDAQ:BOFI). Alpha Cubed Invests Limited Liability accumulated 12,100 shares or 0.05% of the stock.

Among 8 analysts covering Bofl Holding Inc (NASDAQ:BOFI), 6 have Buy rating, 0 Sell and 2 Hold. Therefore 75% are positive. Bofl Holding Inc had 28 analyst reports since August 5, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Friday, July 31 by FBR Capital. The company was downgraded on Monday, October 9 by Wood. FBR Capital maintained it with “Buy” rating and $45.0 target in Wednesday, March 7 report. The firm has “Buy” rating by Sandler O’Neill given on Wednesday, January 31. The rating was downgraded by Raymond James on Monday, April 2 to “Outperform”. Raymond James upgraded the stock to “Strong Buy” rating in Friday, September 4 report. The company was maintained on Tuesday, January 9 by Sandler O’Neill. On Thursday, February 1 the stock rating was maintained by Stephens with “Buy”. As per Thursday, March 22, the company rating was maintained by Keefe Bruyette & Woods. On Thursday, December 21 the stock rating was maintained by Keefe Bruyette & Woods with “Hold”.

BofI Holding, Inc. (NASDAQ:BOFI) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: